Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
Regulatory Info :
Registration Country : Sweden
Brand Name : Aranesp
Dosage Form : SOLUTION FOR INJECTION
Dosage Strength : 300 MICROGRAMS
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Aranesp
Dosage Form : SOLUTION FOR INJECTION
Dosage Strength : 200 MICROGRAM
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Aranesp
Dosage Form : SOLUTION FOR INJECTION, PRE-FILLED SYRINGE
Dosage Strength : 130 MICROGRAMS
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Aranesp
Dosage Form : SOLUTION FOR INJECTION, PRE-FILLED SYRINGE
Dosage Strength : 50 G
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Switzerland
Brand Name : Aranesp
Dosage Form : Including
Dosage Strength : 10mcg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Aranesp
Dosage Form : Inj Solution
Dosage Strength : 300mcg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : ARANESP
Dosage Form : SOLUTION
Dosage Strength : 200MCG/ML
Packaging : Apr-16
Approval Date :
Application Number : 2391775
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info :
Registration Country : Australia
Brand Name : Aranesp
Dosage Form : injection
Dosage Strength : 10 microgram/0.4 mL
Packaging : 4
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Aranesp
Dosage Form : injection
Dosage Strength : 60 microgram/0.3 mL
Packaging : 4
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Aranesp SureClick
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
Finished Drug Prices
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Annual Reports
Main Therapeutic Indication : Hematology
Currency : USD
2020 Revenue in Millions : 1,568
2019 Revenue in Millions : 1,729
Growth (%) : -9
Main Therapeutic Indication : Hematology
Currency : USD
2021 Revenue in Millions : 1,480
2020 Revenue in Millions : 1,568
Growth (%) : -6
Main Therapeutic Indication : Nephrology
Currency : USD
2020 Revenue in Millions : 99
2019 Revenue in Millions : 378
Growth (%) : -74
Main Therapeutic Indication : Nephrology
Currency : USD
2020 Revenue in Millions : 239
2019 Revenue in Millions : 133
Growth (%) : 80
Main Therapeutic Indication : Nephrology
Currency : USD
2021 Revenue in Millions : 188
2020 Revenue in Millions : 239
Growth (%) : -12
Main Therapeutic Indication : Nephrology
Currency : USD
2021 Revenue in Millions : 88
2020 Revenue in Millions : 99
Growth (%) : 0
Main Therapeutic Indication : Nephrology
Currency : USD
2022 Revenue in Millions : 83
2021 Revenue in Millions : 88
Growth (%) : -5
Main Therapeutic Indication : Nephrology
Currency : USD
2022 Revenue in Millions : 133
2021 Revenue in Millions : 188
Growth (%) : -29
Main Therapeutic Indication : Hematology
Currency : USD
2022 Revenue in Millions : 1,421
2021 Revenue in Millions : 1,480
Growth (%) : -4
Main Therapeutic Indication : Nephrology
Currency : USD
2023 Revenue in Millions : 83
2022 Revenue in Millions : 83
Growth (%) : 12
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
